Tumor microenvironment: Hypoxia and buffer capacity for immunotherapy

Medical Hypotheses

Volumn 69, Issue 3, 2007, Pages 590-595

  Liu, Chenghu ^a   Gao, Shangxian ^a,b   Qu, Zhonghua ^a   Zhang, Lining ^a  

^a SHANDONG UNIVERSITY   (China)

^b NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BUFFER; CD4 ANTIGEN; CD8 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; NATURAL KILLER CELL RECEPTOR NKG2D; TRANSCRIPTION FACTOR FOXP3; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ARTICLE; CANCER IMMUNOTHERAPY; CANCER PATIENT; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DENDRITIC CELL; HUMAN; HYPOXIA; IMMUNOCOMPETENT CELL; IMMUNOSTIMULATION; MELANOMA; MICROENVIRONMENT; NATURAL KILLER CELL; NONHUMAN; OXYGEN TENSION; PATHOGENESIS; PH; PRIORITY JOURNAL; PROGNOSIS; PROPIONIBACTERIUM ACNES; REGULATORY T LYMPHOCYTE; TUMOR ASSOCIATED LEUKOCYTE; TUMOR GROWTH;

ANIMALS; ANOXIA; BUFFERS; CD4-POSITIVE T-LYMPHOCYTES; DENDRITIC CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; IMMUNE SYSTEM; IMMUNOTHERAPY; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; KILLER CELLS, NATURAL; MELANOMA; MODELS, BIOLOGICAL; PROPIONIBACTERIUM ACNES; TREATMENT OUTCOME;

PROPIONIBACTERIUM ACNES;

EID: 34447278146     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.12.053     Document Type: Article

References (26)

1. Rosenberg S.A., Spiess P., and Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 233 4770 (1986) 1318-1321
2. Loeffler D.A., Keng P.C., Baggs R.B., and Lord E.M. Lymphocytic infiltration and cytotoxicity under hypoxic conditions in the EMT6 mouse mammary tumor. Int J Cancer 45 3 (1990) 462-467
3. 2 homeostasis by hypoxia-inducible factor 1 alpha. Genes Dev 12 2 (1998) 149-162
4. Hori S., Nomura T., and Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science 299 4 (2003) 1057-1061
5. + regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 22 (2004) 531-562
6. + immunoregulatory cells. J Immunol 167 3 (2001) 1137-1140
7. Antony P.A., Piccirillo C.A., Akpinarli A., Finkelstein S.E., Speiss P.J., Surman D.R., et al. CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells. J Immunol 174 5 (2005) 2591-2601
8. Mellman I., and Steinman R.M. Dendritic cells: specialized and regulated antigen processing machines. Cell 106 3 (2001) 255-258
9. Suciu-Foca N., Manavalan J.S., and Cortesini R. Generation and function of antigen-specific suppressor and regulatory T cells. Transpl Immunol 11 3-4 (2003) 235-244
10. Cortesini R., LeMaoult J., Ciubotariu R., and Cortesini N.S. CD8+CD28 - T suppressor cells and the induction of antigen-specific, antigen-presenting cell-mediated suppression of Th reactivity. Immunol Rev 182 1 (2001) 201-206
11. Yamazaki S., Iyoda T., Tarbell K., Olson K., Velinzon K., Inaba K., et al. Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 198 2 (2003) 235-247
12. Yang Y., Huang C.T., Huang X., and Pardoll D.M. Persistent toll-like receptor signals are required for reversal of regulatory T cell-mediated CD8 tolerance. Nat Immunol 5 5 (2004) 508-515
13. Zhang M., Tang H., Guo Z., An H., Zhu X., Song W., et al. Splenic stroma drives mature dendritic cells to differentiate into regulatory dendritic cells. Nat Immunol 5 11 (2004) 1124-1133
14. Chen w. Dendritic cells and CD4+CD25+ T regulatory cells: crosstalk between two professionals in immunity versus tolerance. Front Biosci 11 (2006) 1360-1370
15. Wei S., Kryczek I., Zou L., Daniel B., Cheng P., Mottram P., et al. Plasmacytoid dendritic cells induce CD8+ regulatory T cells in human ovarian carcinoma. Cancer Res 65 12 (2005) 5020-5026
16. Gerosa F., Gobbi A., Zorzi P., Burg S., Briere F., Carra G., et al. The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174 2 (2005) 727-734
17. Mailliard R.B., Son Y.I., Redlinger R., Coates P.T., Giermasz A., Morel P.A., et al. Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 171 5 (2003) 2366-2373
18. Hayakawa Y., Screpanti V., Yagita H., Grandien A., Ljunggren H.G., Smyth M.J., et al. NK cell TRAIL eliminates immature dendritic cells in vivo and limits dendritic cell vaccination efficacy. J Immunol 172 1 (2004) 123-129
19. Fernandez N.C., Flament C., Crepineau F., Angevin E., Vivier E., and Zitvogel L. Dendritic cells (DC) promote natural killer (NK) cell functions: dynamics of the human DC/NK cell cross talk. Eur Cytokine Netw 13 1 (2002) 17-27
20. Schmitz M., Zhao S., Deuse Y., Schakel K., Wehner R., Wohner H., et al. Tumoricidal potential of native blood dendritic cells: direct tumor cell killing and activation of NK cell-mediated cytotoxicity. J Immunol 174 7 (2005) 4127-4134
21. Lanier L.L., Spits H., and Phillips J.H. The developmental relationship between NK cells and T cells. Immunol Today 13 10 (1992) 392-395
22. Valiante N.M., and Parham P. NK cells and CTL: opposite sides of the same coin. Chem Immunol 64 (1996) 146-163
23. Wang J., Sun R., Wei H., Dong Z., and Tian Z. Pre-activation of T lymphocytes by low dose of concanavalin A aggravates toll-like receptor-3 ligand-induced NK cell-mediated liver injury. Int Immunopharmacol 6 5 (2006) 800-807
24. Seo N., Tokura Y., Furukawa F., and Takigawa M. Down-regulation of tumoricidal NK and NK T cell activities by MHC Kb molecules expressed on Th2-type gammadelta T and alphabeta T cells coinfiltrating in early B16 melanoma lesions. J Immunol 161 8 (1998) 4138-4145
25. Smyth M.J., Teng M.W., Swann J., Kyparissoudis K., Godfrey D.I., and Hayakawa Y. CD4+CD25+ T regulatory cells suppress NK cell-mediated immunotherapy of cancer. J Immunol 176 3 (2006) 1582-1587
26. Vogelstein B., and Kinzler K.W. The multistep nature of cancer. Trends Genet 9 4 (1993) 138-141